ringoba tabletta
deutsche homöopathie union gmbh&co.kg - magnézium-karbonát -
paracetamol pxgpharma 500 mg filmtabletta
pxg pharma gmbh - a paracetamol -
cetirizine pxgpharma 10 mg filmtabletta
pxg pharma gmbh - cetirizin-dihidroklorid -
imfinzi
astrazeneca ab - durvalumab - karcinóma, nem kissejtes tüdő - daganatellenes szerek - non-small cell lung cancer (nsclc)imfinzi as monotherapy is indicated for the treatment of locally advanced, unresectable non small cell lung cancer (nsclc) in adults whose tumours express pd-l1 on ≥ 1% of tumour cells and whose disease has not progressed following platinum based chemoradiation therapy (see section 5. imfinzi in combination with tremelimumab and platinum-based chemotherapy is indicated for the first-line treatment of adults with metastatic nsclc with no sensitising egfr mutations or alk positive mutations. small cell lung cancer (sclc)imfinzi in combination with etoposide and either carboplatin or cisplatin is indicated for the first-line treatment of adults with extensive-stage small cell lung cancer (es-sclc). biliary tract cancer (btc)imfinzi in combination with gemcitabine and cisplatin is indicated for the first line treatment of adults with unresectable or metastatic biliary tract cancer (btc). hepatocellular carcinoma (hcc)imfinzi in combination with tremelimumab is indicated for the first line treatment of adults with advanced or unresectable hepatocellular carcinoma (hcc).
humafactor-9 1200 ne por és oldószer oldatos injekcióhoz
human bioplazma kft. - ix-es faktor, humán véralvadási -
humafactor-9 300 ne por és oldószer oldatos injekcióhoz
human bioplazma kft. - ix-es faktor, humán véralvadási -
humafactor-9 600 ne por és oldószer oldatos injekcióhoz
human bioplazma kft. - ix-es faktor, humán véralvadási -
cinacalcet teva 30 mg filmtabletta
teva gyógyszergyár zrt. - cinakalcet-hidroklorid -
cinacalcet teva 60 mg filmtabletta
teva gyógyszergyár zrt. - cinakalcet-hidroklorid -
cinacalcet teva 90 mg filmtabletta
teva gyógyszergyár zrt. - cinakalcet-hidroklorid -